Source link : https://newshealth.biz/health-news/novel-alzheimers-drug-targeting-tau-shows-promise-in-mid-stage-trial/
The tau-targeting agent diranersen did not meet the primary endpoint of the phase II CELIA trial, but that isn’t stopping the drug from moving forward. The placebo-controlled study is the first to show a cognitive benefit and a reduction in tau pathology in people with early Alzheimer’s disease, reported Catherine Mummery, MBBS, PhD, of University […]
The post Novel Alzheimer’s Drug Targeting Tau Shows Promise in Mid-Stage Trial first appeared on News Health.
—-
Author : News Health
Publish date : 2026-07-14 20:28:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8